📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Tranexamic acid in traumatic brain injury: an explanatory study nested within the CRASH-3 trial. (2021)

First Author: CRASH-3 Intracranial Bleeding Mechanistic Study Collaborators

Attributed to: The CRASH-3 Trial: Tranexamic acid for the treatment of significant traumatic brain injury. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00068-020-01316-1

PubMed Identifier: 32076783

Publication URI: http://europepmc.org/abstract/MED/32076783

Type: Journal Article/Review

Volume: 47

Parent Publication: European journal of trauma and emergency surgery : official publication of the European Trauma Society

Issue: 1

ISSN: 1863-9933